tenk.fyi

Scilex Holding Co

SCLXNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$56.6M

21.1% YoY

Net Income

-$72.8M

36.3% YoY

EPS

$-0.61

52.3% YoY

Cash

$3.3M

16.6% YoY

FY 2024 · As of 2024-12-31